SMT201700032B - Nuovi derivati di (aza)benzidril etere, loro processo di preparazione, e loro uso come ligandi del recettore h4 per applicazioni terapeutiche - Google Patents
Nuovi derivati di (aza)benzidril etere, loro processo di preparazione, e loro uso come ligandi del recettore h4 per applicazioni terapeuticheInfo
- Publication number
- SMT201700032B SMT201700032B SM201700032T SM201700032T SMT201700032B SM T201700032 B SMT201700032 B SM T201700032B SM 201700032 T SM201700032 T SM 201700032T SM 201700032 T SM201700032 T SM 201700032T SM T201700032 B SMT201700032 B SM T201700032B
- Authority
- SM
- San Marino
- Prior art keywords
- benzidril
- etere
- aza
- ligands
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305632.7A EP2671870A1 (en) | 2012-06-05 | 2012-06-05 | Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications |
| EP13170687.1A EP2671871B1 (en) | 2012-06-05 | 2013-06-05 | Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201700032B true SMT201700032B (it) | 2017-03-08 |
Family
ID=48534299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201700032T SMT201700032B (it) | 2012-06-05 | 2017-01-18 | Nuovi derivati di (aza)benzidril etere, loro processo di preparazione, e loro uso come ligandi del recettore h4 per applicazioni terapeutiche |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9242959B2 (it) |
| EP (2) | EP2671870A1 (it) |
| CY (1) | CY1118614T1 (it) |
| DK (1) | DK2671871T3 (it) |
| ES (1) | ES2606381T3 (it) |
| HR (1) | HRP20170052T1 (it) |
| HU (1) | HUE032870T2 (it) |
| LT (1) | LT2671871T (it) |
| PL (1) | PL2671871T3 (it) |
| PT (1) | PT2671871T (it) |
| RS (1) | RS55562B1 (it) |
| SI (1) | SI2671871T1 (it) |
| SM (1) | SMT201700032B (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104693183A (zh) * | 2015-03-23 | 2015-06-10 | 上海皓元化学科技有限公司 | 一种2-[(4-氯苯基)(4-哌啶基氧基)甲基]吡啶及其衍生物的合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2479843A (en) * | 1948-06-02 | 1949-08-23 | Nopco Chem Co | 1-alkylpiperidyl-4-benzhydryl ethers, acid salts thereof and their preparation |
| DE934890C (de) * | 1951-10-07 | 1955-11-10 | Chem Fab Promonta Ges Mit Besc | Verfahren zur Herstellung von basischen Benzhydrylaethern |
| US2745837A (en) * | 1954-01-21 | 1956-05-15 | Schering Corp | Benzhydryl ethers of alkyl piperidinols |
| GB780027A (en) * | 1955-01-20 | 1957-07-31 | Schering Corp | 3-piperidyl ethers and thioethers |
| US2974146A (en) * | 1956-02-24 | 1961-03-07 | Lakeside Lab Inc | 3-piperidyl benzhydryl ethers |
| US3280196A (en) * | 1962-05-25 | 1966-10-18 | S B Penick & Company | Benzhydryl-dihaloalkane ethers |
| HU196194B (en) * | 1986-04-28 | 1988-10-28 | Richter Gedeon Vegyeszet | Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds |
| AU6181196A (en) * | 1995-06-29 | 1997-01-30 | Mcneil-Ppc, Inc. | The combination of topical nasal antihistamines and topical nasal mast cell stabilizers |
| US20070173486A1 (en) * | 2003-05-01 | 2007-07-26 | Vernalis Research Limited | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs |
| EP1673348B1 (en) * | 2003-09-30 | 2009-04-01 | Janssen Pharmaceutica N.V. | Benzoimidazole compounds |
| EP2120945A1 (en) * | 2007-02-28 | 2009-11-25 | Collegium Pharmaceutical, Inc. | Antihistamine combination |
| US20090176792A1 (en) | 2008-01-07 | 2009-07-09 | Auspex Pharmaceuticals, Inc. | Substituted dibenzhydrylpiperazines |
| KR101146009B1 (ko) * | 2009-10-01 | 2012-05-15 | 동인화학 주식회사 | 광학 분리에 의한 활성 피페리딘 화합물의 제조방법 |
| EP2447263A1 (en) * | 2010-09-27 | 2012-05-02 | Bioprojet | Benzazole derivatives as histamine H4 receptor ligands |
-
2012
- 2012-06-05 EP EP12305632.7A patent/EP2671870A1/en not_active Withdrawn
-
2013
- 2013-06-05 DK DK13170687.1T patent/DK2671871T3/en active
- 2013-06-05 RS RS20170013A patent/RS55562B1/sr unknown
- 2013-06-05 US US13/910,651 patent/US9242959B2/en active Active
- 2013-06-05 SI SI201330454A patent/SI2671871T1/sl unknown
- 2013-06-05 EP EP13170687.1A patent/EP2671871B1/en active Active
- 2013-06-05 PT PT131706871T patent/PT2671871T/pt unknown
- 2013-06-05 PL PL13170687T patent/PL2671871T3/pl unknown
- 2013-06-05 ES ES13170687.1T patent/ES2606381T3/es active Active
- 2013-06-05 HU HUE13170687A patent/HUE032870T2/en unknown
- 2013-06-05 LT LTEP13170687.1T patent/LT2671871T/lt unknown
-
2017
- 2017-01-12 HR HRP20170052TT patent/HRP20170052T1/hr unknown
- 2017-01-17 CY CY20171100059T patent/CY1118614T1/el unknown
- 2017-01-18 SM SM201700032T patent/SMT201700032B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2671871T (pt) | 2017-01-09 |
| ES2606381T3 (es) | 2017-03-23 |
| EP2671871B1 (en) | 2016-10-19 |
| EP2671870A1 (en) | 2013-12-11 |
| RS55562B1 (sr) | 2017-05-31 |
| US20130324507A1 (en) | 2013-12-05 |
| DK2671871T3 (en) | 2017-01-16 |
| HRP20170052T1 (hr) | 2017-05-05 |
| US9242959B2 (en) | 2016-01-26 |
| EP2671871A1 (en) | 2013-12-11 |
| HUE032870T2 (en) | 2017-11-28 |
| PL2671871T3 (pl) | 2017-04-28 |
| SI2671871T1 (sl) | 2017-01-31 |
| LT2671871T (lt) | 2016-12-27 |
| CY1118614T1 (el) | 2017-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600354B (it) | Composti di beta-lattame sostituiti da ammidina, loro preparazione ed uso come agenti antibatterici | |
| SMT201600157B (it) | Composti di carbammoilpiridone policiclici e loro uso farmaceutico | |
| CL2014003165A1 (es) | Proceso mejorado para la preparación de treprostinil y derivados del mismo. | |
| IL238662A (en) | Bandostatin derivatives, containing them and used to treat cancer | |
| IL266300B (en) | Antecedents of glutarimide, their use, a pharmaceutical preparation based on them and methods for producing antecedents of glutarimide | |
| BR112015002755A2 (pt) | derivado de ácido hialurônico, método de preparação de derivado de ácido hialurônico, método de modificação de derivado de ácido hialurônico e uso de derivados | |
| BR112014028723A2 (pt) | forma cristalina, seu processo de produção e mistura, agente de proteção, uso da forma cristalina e método para o combate | |
| BR112015008113A2 (pt) | novo processo para preparar compostos para uso no tratamento de câncer. | |
| BR112014026564A2 (pt) | formulação, uso de uma formulação, e, processo para a preparação de uma formulação | |
| BR112014026565A2 (pt) | formulação, uso de uma formulação, e, processo para produzir uma formulação | |
| CL2014001862A1 (es) | Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia. | |
| SMT201600215B (it) | Derivati dello sterolo, metodo per preparare gli stessi, composizioni farmaceutiche contenenti gli stessi e loro uso per il trattamento del glioblastoma multiforme | |
| HK1211570A1 (en) | Indene derivatives, their preparation and use as medicaments | |
| SMT201700113B (it) | Derivati fotoreticolati di acido ialuronico, loro processo di preparazione ed impiego | |
| HK1212968A1 (zh) | 氨基環丁烷衍生物、其製備方法及其用作藥物的用途 | |
| SMT201700032B (it) | Nuovi derivati di (aza)benzidril etere, loro processo di preparazione, e loro uso come ligandi del recettore h4 per applicazioni terapeutiche | |
| DK3081560T3 (da) | Taxanforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| BR112014031508A2 (pt) | composição alimentícia concentrada, processo e uso de composição | |
| FI20136136A (fi) | Menetelmä kosmeettisten koostumusten valmistamiseksi, kosmeettiset koostumukset sekä niiden käyttö | |
| BR112015011392A2 (pt) | formas polimórficas de ácidos, processo de preparação, composição farmacêutica e uso das mesmas | |
| ITVI20130143A1 (it) | Processo migliorato per la preparazione di 3-amminopiperidina e suoi derivati | |
| BR112015003033A2 (pt) | composto, composição farmacêutica e uso do composto | |
| ITRM20130588A1 (it) | Derivati di chinossalina, metodi per la loro produzione e loro uso come agenti antitumorali. | |
| PL395184A1 (pl) | Nowe pochodne benzimidazolu, sposób wytwarzania i zastosowanie pochodnych benzimidazolu | |
| HUP1300393A2 (en) | Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same |